Cell Growth & Differentiation, Vol 6, Issue 10 1287-1298, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation

M Kiess, RM Gill and PA Hamel
Department of Cellular and Molecular Pathology, University of Toronto, Ontario, Canada.

The activity of the E2 F-family of transcription factors is tightly linked to control of the cell cycle. p107 and p130, two closely related members of the retinoblastoma protein-family of negative cell cycle regulators, modulate the activity of the E2f-family proteins by direct interaction with these factors. To understand the role of p107 and p130 in progression through or exit from the cell cycle, we have characterized the expression, phosphorylation state, cyclin-binding, and E2f-binding activity of p107 and p130 during terminal differentiation of rat myoblast cells into immature skeletal muscle (myotubes). In exponentially growing L6 myoblasts, p107 is phosphorylated in a cell cycle-dependent manner, and E2f-site binding complexes containing p107 is phosphorylated in a cell cycle-dependent manner, and E2f-site binding complexes containing p107 can be observed throughout the cell cycle. During differentiation of L6 cells, p107 levels are reduced, while p130 protein levels are increased 8-fold. Despite both p107 and p130 becoming hypophosphorylated during myogenesis, the E2F-site DNA-binding complexes containing p107 observed in exponentially growing myoblasts are quantitatively replaced in myotubes with complexes containing only p130. In myotubes, p107 is not associated with E2f-family proteins that are capable of binding DNA. The failure to observe p107-containing complexes in myotubes appears to be due to the differentiation-specific induction of both p130 and cyclin D3, p107 is found in complexes with cyclin D3 in myotubes, and the addition of exogenous cyclin D3 or p130 to lysates from undifferentiated L6 cells was able to disrupt p107-containing E2F-site binding complexes. In myotubes, p130 also forms complexes with cyclin D3 as well as cyclin E, cdk2, and cdk4. We are able to copurify cyclin D3 with cyclin E from myotubes, indicating the presence of a macromolecular complex containing both cyclin E and cyclin D3 simultaneously bound to p130. Thus, in myoblasts, p107 is normally involved in regulation of E2f-family proteins during cell cycle progression, while p130 is a differentiation-specific regulator of E2f activity. Our results also provide evidence that the apparent positive regulator of cell cycle progression, cyclin D3, has a function in terminally differentiated muscle cells.

This article has been cited by other articles:

				R. Parakati and J. X. DiMario Dynamic Transcriptional Regulatory Complexes, Including E2F4, p107, p130, and Sp1, Control Fibroblast Growth Factor Receptor 1 Gene Expression during Myogenesis J. Biol. Chem., June 3, 2005; 280(22): 21284 - 21294. [Abstract] [Full Text] [PDF]

				N. Olashaw and W. J. Pledger Paradigms of Growth Control: Relation to Cdk Activation Sci. Signal., May 28, 2002; 2002(134): re7 - re7. [Abstract] [Full Text] [PDF]

				N. A. Timchenko, P. Iakova, Z.-J. Cai, J. R. Smith, and L. T. Timchenko Molecular Basis for Impaired Muscle Differentiation in Myotonic Dystrophy Mol. Cell. Biol., October 15, 2001; 21(20): 6927 - 6938. [Abstract] [Full Text] [PDF]

				J. W. Harbour and D. C. Dean The Rb/E2F pathway: expanding roles and emerging paradigms Genes & Dev., October 1, 2000; 14(19): 2393 - 2409. [Full Text]

				Q. M. Wang, R. Feinman, F. Kashanchi, J. M. Houghton, G. P. Studzinski, and L. E. Harrison Changes in E2F Binding after Phenylbutyrate-induced Differentiation of Caco-2 Colon Cancer Cells Clin. Cancer Res., July 1, 2000; 6(7): 2951 - 2958. [Abstract] [Full Text]

				S. L. Chen, D. H. Dowhan, B. M. Hosking, and G. E.O. Muscat The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation Genes & Dev., May 15, 2000; 14(10): 1209 - 1228. [Abstract] [Full Text]

				C. M. Francesconi, A. E. K. Hutcheon, E.-H. Chung, A. C. Dalbone, N. C. Joyce, and J. D. Zieske Expression Patterns of Retinoblastoma and E2F Family Proteins during Corneal Development Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1054 - 1062. [Abstract] [Full Text]

				R. M. Gill and P. A. Hamel Subcellular Compartmentalization of E2F Family Members Is Required for Maintenance of the Postmitotic State in Terminally Differentiated Muscle J. Cell Biol., March 20, 2000; 148(6): 1187 - 1202. [Abstract] [Full Text] [PDF]

				Q. Ding, Q. Wang, Z. Dong, and B. M. Evers Characterization and regulation of E2F activity during Caco-2 cell differentiation Am J Physiol Cell Physiol, January 1, 2000; 278(1): C110 - C117. [Abstract] [Full Text] [PDF]

				C. Cenciarelli, F. De Santa, P. L. Puri, E. Mattei, L. Ricci, F. Bucci, A. Felsani, and M. Caruso Critical Role Played by Cyclin D3 in the MyoD-Mediated Arrest of Cell Cycle during Myoblast Differentiation Mol. Cell. Biol., July 1, 1999; 19(7): 5203 - 5217. [Abstract] [Full Text] [PDF]

				P. Bailey, M. Downes, P. Lau, J. Harris, S. L. Chen, Y. Hamamori, V. Sartorelli, and G. E. O. Muscat The Nuclear Receptor Corepressor N-CoR Regulates Differentiation: N-CoR Directly Interacts with MyoD Mol. Endocrinol., July 1, 1999; 13(7): 1155 - 1168. [Abstract] [Full Text]

				K. Smith-McCune, D. Kalman, C. Robbins, S. Shivakumar, L. Yuschenkoff, and J. M. Bishop Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130 PNAS, June 8, 1999; 96(12): 6999 - 7004. [Abstract] [Full Text] [PDF]

				N. Saadane, L. Alpert, and L. E. Chalifour TAFII250, Egr-1, and D-type cyclin expression in mice and neonatal rat cardiomyocytes treated with doxorubicin Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H803 - H814. [Abstract] [Full Text] [PDF]

				B. Harvat, A Wang, P Seth, and A. Jetten Up-regulation of p27Kip1, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation J. Cell Sci., January 5, 1998; 111(9): 1185 - 1196. [Abstract] [PDF]

				A. De Luca, T. K. MacLachlan, L. Bagella, C. Dean, C. M. Howard, P. P. Claudio, A. Baldi, K. Khalili, and A. Giordano A Unique Domain of pRb2/p130 Acts as an Inhibitor of Cdk2 Kinase Activity J. Biol. Chem., August 22, 1997; 272(34): 20971 - 20974. [Abstract] [Full Text] [PDF]

				K. Helin, K. Holm, A. Niebuhr, H. Eiberg, N. Tommerup, S. Hougaard, H. S. Poulsen, M. Spang-Thomsen, and P. Norgaard Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma PNAS, June 24, 1997; 94(13): 6933 - 6938. [Abstract] [Full Text] [PDF]

				V. M. Richon, R. E. Lyle, and R. E. McGehee Jr. Regulation and Expression of Retinoblastoma Proteins p107 and p130 during 3T3-L1 Adipocyte Differentiation J. Biol. Chem., April 11, 1997; 272(15): 10117 - 10124. [Abstract] [Full Text] [PDF]

				T. Murai, Y. Nakagawa, H. Maeda, and K. Terada Altered Regulation of Cell Cycle Machinery Involved in Interleukin-1-induced G1 and G2 Phase Growth Arrest of A375S2 Human Melanoma Cells J. Biol. Chem., February 23, 2001; 276(9): 6797 - 6806. [Abstract] [Full Text] [PDF]